Evidence map›Paper›PMID 20033060›Full record

ArticleThe EMBO journal2010

DHPR alpha1S subunit controls skeletal muscle mass and morphogenesis.

France Piétri-Rouxel, Christel Gentil, Stéphane Vassilopoulos, Dominique Baas, Etienne Mouisel, Arnaud Ferry, Alban Vignaud, Christophe Hourdé, Isabelle Marty, Laurent Schaeffer and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. In vivo RyR1 reduction in muscle triggers a core-like myopathy.Acta neuropathologica communications · 2020
    Article
  11. Equivalent L-type channel (CaBiochemical and biophysical research communications · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Deletion ofInternational journal of molecular sciences · 2018
    Article
  16. A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  17. Review
  18. Review of RyR1 pathway and associated pathomechanisms.Acta neuropathologica communications · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

France Piétri-RouxelUMR 7215, CNRS, UMR S 974 Inserm, Institut de Myologie, Université Pierre et Marie Curie, Paris, France. france.pietri-rouxel@upmc.fr
Christel Gentil
Stéphane Vassilopoulos
Dominique Baas
Etienne Mouisel
Arnaud Ferry
Alban Vignaud
Christophe Hourdé
Isabelle Marty
Laurent Schaeffer
Thomas Voit
Luis Garcia
Centre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRDélégation Paris 5 · FRInserm · FRUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The alpha1S subunit has a dual function in skeletal muscle: it forms the L-type Ca(2+) channel in T-tubules and is the voltage sensor of excitation-contraction coupling at the level of triads. It has been proposed that L-type Ca(2+) channels might also be voltage-gated sensors linked to transcriptional activity controlling differentiation. By using the U7-exon skipping strategy, we have achieved long-lasting downregulation of alpha1S in adult skeletal muscle. Treated muscles underwent massive atrophy while still displaying significant amounts of alpha1S in the tubular system and being not paralysed. This atrophy implicated the autophagy pathway, which was triggered by neuronal nitric oxide synthase redistribution, activation of FoxO3A, upregulation of autophagy-related genes and autophagosome formation. Subcellular investigations showed that this atrophy was correlated with the disappearance of a minor fraction of alpha1S located throughout the sarcolemma. Our results reveal for the first time that this sarcolemmal fraction could have a role in a signalling pathway determining muscle anabolic or catabolic state and might act as a molecular sensor of muscle activity.

Indexed as

AnimalsAutophagyBase SequenceCalcium ChannelsCalcium Channels, L-TypeCells, CulturedMiceMice, Inbred C57BLMice, KnockoutMolecular Sequence DataMorphogenesisMuscle, SkeletalMuscle StrengthMuscular AtrophyNitric Oxide Synthase Type IOrgan SizeCACNA1S protein, mouseCalcium ChannelsCalcium Channels, L-TypeNitric Oxide Synthase Type IProtein Subunits

Identifiers

PMID20033060
PMCPMC2830706
OpenAlexW2012747296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.